MIT Engineers Create Nanoparticles for Delivering Personalized Cancer Vaccines

Engineers at MIT have developed a nanoscale particle delivery system for personalized cancer vaccines. This system, based on a modified bacteriophage, can be coated with cancer antigens at controlled densities, demonstrating effectiveness in preventing colon tumors in mice. This breakthrough could enable customized vaccines to treat individual patients' tumors.